A recent research article published in the scientific journal Emergency Medicine News discussed the recent trends in declining opioid overdose deaths in the U.S., as well as the alarming racial and ethnic disparities in these health trends. Moreover, the article emphasis the need for emergency departments to adapt to the evolving demographics of the epidemic.
According to the Centers for Disease Control and Prevention (CDC), in 2023, opioid overdose deaths in the U.S. decreased 3% nationwide and by 10% in states including New York. In addition, there was a 24% decrease in opioid-related overdose deaths between October 2023 and September 2024 compared to the previous year.
The article discussed the four waves of the opioid epidemic in the U.S., which have affected communities differently. Specifically, the third and fourth waves of the opioid crisis have significantly increased health disparities, particularly among African-American, Indigenous, and people of colour communities.
The first wave of the opioid epidemic, which took place from 1990 to 2010, was driven by overprescribing and aggressive pharmaceutical marketing, which resulted in a surge in prescription opioid overdoses, primarily affecting non-Hispanic White adults aged 45-54 years. The second wave, which took place from 2010 to 2013, involved the transition from prescription opioids to heroin due to stricter prescription regulation, with rising overdoses notably among non-Hispanic African-American individuals aged 45-64 years. Subsequently, the third wave of the epidemic, which lasted between 2013 and 2019, resulted from the increase in use of synthetic opioids like fentanyl, and disproportionately impacted younger adults and non-Hispanic African-American communities, leading to a significant increase in overdose deaths. Finally, the fourth wave, which has lasted from 2019 until the present, was influenced by fentanyl contaminated with stimulants and sedatives such as xylazine, and has intensified overdose risks and disparities, especially among African-American, Hispanic, and Indigenous populations.
“Recent shifts in overdose death rates across races demonstrate the systemic issues in the U.S. healthcare system, including health inequities, discrimination, and implicit bias,” wrote the authors. “To begin addressing these health inequities, EDs must employ various interventions for OUD to meet patients where they are; these interventions should include initiation of MAT, linkage to outpatient treatment, and distribution of harm reduction supplies.”
The authors also highlighted the New York initiative MATTERS, which quickly connects emergency department patients with opioid use disorder to over 250 treatment centers, providing medication, transport, and follow-up care. For those not ready for treatment, it offers free harm reduction supplies by mail and through 24/7 vending machines.
“Referrals take as little as 3 minutes to complete, and patients are automatically provided with medication and transportation vouchers, peer support referrals, and follow-up services to ensure continuity of care and retention in treatment,” reads the article. “These resources are automatically provided to patients at the time of referral—all without making a single phone call. For individuals who are not ready for treatment, MATTERS distributes free harm reduction supplies, including drug checking strips, naloxone, and sterile syringes via direct mail.”
The authors conclude that to begin addressing these health disparities, emergency departments must employ various interventions for opioid use disorder to “meet patients where they are.” They suggest that such interventions should include initiation of medications for addiction treatment, linkage to outpatient treatment, and distribution of harm reduction supplies, such as naloxone.